ArticleCurrent cancer drug targets2024

The Efficacy and Safety of Inetetamab and Pyrotinib in Combination with Vinorelbine for Second-line Therapy and Beyond in HER2-positive Metastatic Breast Cancer: A Single-institution Clinical Experience.

Fan Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.